Gala Pharmaceutical Inc. Share-based Payment Arrangement, Expense
Gala Pharmaceutical Inc. reported Share-based Payment Arrangement, Expense of $213.35 thousand for the 9-month period ending 2018-08-31, per its 10-Q filed 2018-10-26.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2018-10-26
- Gala Pharmaceutical Inc. share-based payment arrangement, expense for the quarter ending 2018-08-31 was $38.59K, a 3858600.00% increase year-over-year.
- Gala Pharmaceutical Inc. share-based payment arrangement, expense for the quarter ending 2018-05-31 was $43.95K, a 45.50% decline year-over-year.
- Gala Pharmaceutical Inc. share-based payment arrangement, expense for the quarter ending 2017-08-31 was $1.00.
- Gala Pharmaceutical Inc. share-based payment arrangement, expense for the quarter ending 2017-05-31 was $80.63K.
- Gala Pharmaceutical Inc. share-based payment arrangement, expense for fiscal 2016 was $26.35K, a 78.00% decline from fiscal 2015.
- Gala Pharmaceutical Inc. share-based payment arrangement, expense for fiscal 2015 was $119.82K.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 12 month |
|---|---|---|---|---|
| 2018-08-31 | $38.59K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-26 | $82.53K derived: sum of 2 quarters · filed 2018-10-26 | $213.35K 10-Q · filed 2018-10-26 | |
| 2018-05-31 | $43.95K 10-Q · filed 2018-08-01 | $174.77K 10-Q · filed 2018-08-01 | ||
| 2017-08-31 | $1.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-26 | $80.63K derived: sum of 2 quarters · filed 2018-10-26 | $210.78K 10-Q · filed 2018-10-26 | |
| 2017-05-31 | $80.63K 10-Q · filed 2018-08-01 | $210.78K 10-Q · filed 2018-08-01 | ||
| 2016-11-30 | -$47.50K derived: 10-K/A 12 month − 10-Q 9 month · filed 2017-03-23 | $26.35K 10-K/A · filed 2017-03-23 | ||
| 2016-08-31 | $73.86K 10-Q · filed 2016-11-04 | |||
| 2015-11-30 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2017-03-23 | $42.87K derived: sum of 2 quarters · filed 2017-03-23 | $119.82K 10-K/A · filed 2017-03-23 | |
| 2015-08-31 | $42.87K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-04 | $119.82K 10-Q · filed 2016-11-04 | ||
| 2015-05-31 | $76.95K 10-Q · filed 2016-07-15 |